Status:
COMPLETED
Pediatric Second Influenza Dose Portal Reminder Recall
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Influenza
Respiratory Tract Infections
Eligibility:
All Genders
6-36 years
Phase:
NA
Brief Summary
This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. The study design is a parallel 2-arm trial. The parallel arms are 1) a reminder...
Detailed Description
This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System, using a parallel 2-arm trial. Sub-optimal vaccination rates are a significant p...
Eligibility Criteria
Inclusion
- Patient within the UCLA Health System identified as a primary care patient per an internal algorithm
- Identified as being overdue for a second dose of influenza vaccine.
Exclusion
- Patient within the UCLA Health System not identified as a primary care patient per an internal algorithm
- Not due for a second dose of influenza vaccine.
Key Trial Info
Start Date :
December 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
698 Patients enrolled
Trial Details
Trial ID
NCT04668417
Start Date
December 15 2020
End Date
April 1 2021
Last Update
May 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California LA
Los Angeles, California, United States, 99095